Your browser doesn't support javascript.
loading
[Safety evaluation and risk control measures of Psoralea corylifolia].
Tian, Wen-Yang; Lan, Shan; Zhang, Li; Sun, Lu; Huang, Ju-Kai; Yang, Xiao-Hui; Sun, Gui-Bo; Gao, Xue-Min; Sun, Xiao-Bo.
Afiliación
  • Tian WY; Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100078, China.
  • Lan S; Sichuan Center for Food and Drug Evaluation, Inspection and Monitorin, Chengdu 610017, China.
  • Zhang L; Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100078, China.
  • Sun L; Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100078, China.
  • Huang JK; Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100078, China.
  • Yang XH; Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100078, China.
  • Sun GB; Institute of Medicinal Plants, Chinese Academy of Medical Sciences, Beijing 100193, China.
  • Gao XM; Beijing University of Chinese Medicine, Beijing 100029, China.
  • Sun XB; Institute of Medicinal Plants, Chinese Academy of Medical Sciences, Beijing 100193, China.
Zhongguo Zhong Yao Za Zhi ; 42(21): 4059-4066, 2017 Nov.
Article en Zh | MEDLINE | ID: mdl-29271140
ABSTRACT
Through a systematic and comprehensive study of domestic and foreign literatures and information, this study aims to trace the herbal origin and the toxicity recorded in ancient and current documents, analyze the safety case reports of Psoralea corylifolia and experimental studies on toxicity in recent years, and make a preliminary summary about the clinical characteristics and potential risk factors of cases related to the safety of P. corylifolia and its preparations. The study involved 84 patients in the safety case reports of P. corylifolia. The adverse events were mainly liver damage (55.95%) and light toxic contact dermatitis (38.10%), sugguesting that P. corylifolia may lead to liver damage and photo toxicity. However, reproductive toxicity and renal damage were only reported in animal studies, but not in clinical reports. Because of its complicated ingredients, the toxic components and mechanisms of P. corylifolia have not been clear at present. Therefore, the authors proposed to strictly apply P. corylifolia in clinic, use it rationally and combine it with other medications. Besides, efforts shall be made to strength the guidance for doctors, the safety monitoring of P. corylifolia and relevant preparations, and actively carry out safety-related basic and clinical studies, so as to give a better guidance to safe medication, full exert the efficacy and avoid the medication risk.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plantas Medicinales / Medicamentos Herbarios Chinos / Psoralea Tipo de estudio: Etiology_studies / Guideline Límite: Animals / Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Asunto de la revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Año: 2017 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plantas Medicinales / Medicamentos Herbarios Chinos / Psoralea Tipo de estudio: Etiology_studies / Guideline Límite: Animals / Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Asunto de la revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Año: 2017 Tipo del documento: Article País de afiliación: China